Thermo Fisher Sci­en­tific In­dia con­ducts Ge­netic So­lu­tions World Tour

BioSpectrum (India) - - BIO CONTENT -

BioEdit .................................................................... 07

BioMail .................................................................... 08

Pol­icy and Reg­u­la­tory News............................... 10

Fi­nance News ......................................................... 12

Start-up News ........................................................ 14

Com­pany News ...................................................... 16

Peo­ple News .......................................................... 45

Sci­ence News ......................................................... 46

Aca­demic News ..................................................... 47

Sup­plier News ........................................................ 48

As part of the Ge­net­ics So­lu­tions World Tour, Thermo Fisher In­dia re­cently or­ga­nized sem­i­nars in Delhi & Ben­galuru to show­case our market lead­er­ship and es­tab­lish new op­por­tu­ni­ties for Sanger se­quenc­ing, Next Gen­er­a­tion Se­quenc­ing (NGS) and Mi­croar­ray.

Ev­ery year, the Ge­netic So­lu­tions Tour is well at­tended by sev­eral Key Opin­ion Lead­ers (KOLs) across the in­dus­try and this year also had ac­tive par­tic­i­pa­tion from 150 re­search sci­en­tists and de­ci­sion mak­ers from more than 50 es­teemed in­sti­tutes and in­dus­trial ac­counts. The high­light for this year’s tour was the launch of two new prod­ucts - Se­qS­tu­dio Ge­netic An­a­lyzer, a low through­put cap­il­lary elec­trophore­sis plat­form for both Sanger se­quenc­ing and DNA frag­ment anal­y­sis and Am­pliSeq On-De­mand Pan­els, a semi-cus­tom panel solution for in­her­ited dis­ease re­search.

In an ef­fort to update a decades-old tech­nol­ogy with­out mak­ing changes to the un­der­ly­ing tried-andtested chem­istry, Thermo Fisher Sci­en­tific has launched the Ap­plied Biosys­tems Se­qS­tu­dio Ge­netic An­a­lyzer, a low-through­put cap­il­lary elec­trophore­sis plat­form for both Sanger se­quenc­ing and DNA frag­ment anal­y­sis.

"Sanger se­quenc­ing us­ing CE, which is cel­e­brat­ing its 40th an­niver­sary this year, is the gold stan­dard of se­quenc­ing tech­nol­ogy. Use of the tech­nol­ogy helped re­searchers dis­cover novel bi­o­log­i­cal find­ings such as the first breast cancer gene (BRCA1), and was used to com­plete the Hu­man Genome Project in 2003," said Kapil Sood, Busi­ness Head - Life Sci­ences So­lu­tions Group, South Asia "The Se­qS­tu­dio Ge­netic An­a­lyzer is a smart, state-of-the-art sys­tem that pro­vides re­searchers with a truly plug and play sys­tem."

Ravi Gupta, Prod­uct Man­age­ment Leader - Cap­il­lary Elec­trophore­sis In­stru­ment at Thermo Fisher Sci­en­tific stated “The Se­qS­tu­dio Ge­netic An­a­lyzer has a small foot­print, with an on-board com­puter and in­te­grated touch­screen that makes run setup quick, in­tu­itive and flex­i­ble. The sys­tem al­lows se­quenc­ing and frag­ment anal­y­sis runs on the same plate with­out the need to change any con­sum­ables. This opens new op­por­tu­ni­ties for stream­lin­ing analy­ses – for ex­am­ple, com­bin­ing a lo­cus screen­ing test with a copy num­ber vari­abil­ity test on the same CE plate”.

It is the first smart con­nected in­stru­ment for sanger se­quenc­ing in the in­dus­try. With cloud-en­abled sys­tem in­te­grated with Thermo Fisher Con­nect cus­tomers can set up run, check its progress, and ac­cess data on the go, all with­out the need to stay in the lab. Cloud-based Ap­plied Biosys­tems™ Sanger Anal­y­sis mod­ules are avail­able for sec­ondary anal­y­sis.

“The plat­form will start ship­ping to early-ac­cess cus­tomers this month and will be broadly avail­able in Septem­ber. For sev­eral months, it has been in the hands of six beta testers across the world who have tested it for dif­fer­ent ap­pli­ca­tions. Among them is MRC Hol­land, a provider of MLPA (mul­ti­plex lig­a­tion-de­pen­dent probe am­pli­fi­ca­tion) kits for DNA copy num­ber quan­tifi­ca­tion. I am very proud to say that we have also started sell­ing the Se­qS­tu­dio to cus­tomers in In­dia. It's been 10 years or more since we've launched a new sys­tem for cap­il­lary elec­trophore­sis and much like a car, at some point, you want to up­grade to a more cur­rent model,” said Sanjiv Karandikar, Di­rec­tor - GSD Sales, Ser­vices & Sup­port, South Asia.

The team also launched an HIV -1 geno­typ­ing kit for CE port­fo­lio and Ion Re­proSeq™ PGS Kits for Ion S5 Sys­tems with more in­no­va­tive prod­ucts such as Ion Tor­rent™ On­comine™ BRCA Re­search As­say which are in launch phase.

Tom Bittick, Sr. Prod­uct Man­ager, at Thermo Fisher Sci­en­tific in­tro­duced the new Ion Am­pliSeq On-De­mand tar­geted se­quenc­ing pan­els for in­her­ited dis­ease re­search. Brief­ing the au­di­ence, he stated, “The new se­quenc­ing pan­els pro­vide easy and prac­ti­cal de­sign cus­tomiza­tion ca­pa­bil­i­ties to lower upfront costs re­gard­less of project size and will sim­plify the way user­scus­tomize their con­tent com­ing in smaller pack size. Clin­i­cal re­searchers can fo­cus on tar­gets of in­ter­est that will drive greater dis­cov­ery with­out the high upfront cost and risk of waste. Com­pared to the time-con­sum­ing and costly whole ex­ome or whole genome se­quenc­ing, tar­geted NGS has be­come an es­pe­cially ben­e­fi­cial ap­proach in clin­i­cal re­search set­tings where a more prac­ti­cal, ef­fi­cient and eco­nom­i­cal way to re-se­quence tens-to-hun­dreds of spe­cific gene tar­gets is of­ten re­quired.”

Kapil Sood and Ravi Gupta un­veil­ing the Se­qS­tu­dio

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.